Analysis of mortality rates due to prostate malignant neoplasms in Austria reveals a fluctuating trend from 2013 to 2023, with values per hundred thousand men showing both peaks and troughs. The year-on-year variations indicate significant shifts, such as a 7.14% increase in 2016 and an 11.11% surge in 2019. However, more recent trends from 2021 to 2023 demonstrated stabilization, with a marginal increase of 1.32% in 2022 and no change in 2023. The Compound Annual Growth Rate (CAGR) over the last five years positions itself at 2%, reflecting an overall increasing trend.
Looking ahead, the forecast data from 2024 to 2028 shows a continuation of this gradual upward trend, albeit at a slower rate, with a forecasted 5-year CAGR of 0.19% translating to a minimal increase of 0.97% over five years. Notable trends to watch for include emerging medical interventions, public health policies aimed at early detection, and lifestyle changes that could impact these mortality rates.
